Lymph node removal with or without stomach-sparing surgery after incomplete ESD for early stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether removing nearby lymph nodes is enough, or if additional stomach-sparing surgery is needed, after a previous endoscopic procedure did not completely remove early stomach cancer. The goal is to see which approach is better for preventing cancer from spreading.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an endoscopic procedure (ESD) for early stomach cancer, but it did not fully remove the cancer.
- The incomplete removal was due to cancer cells in lymph or blood vessels, or at the deep edge of the removed tissue, or invasion deeper than the surface layer.
- Your cancer was located more than 2 cm away from the top or bottom openings of your stomach.
- You are healthy enough for surgery and have not had radiation to your upper abdomen.
- You are not pregnant and are not allergic to the dye used in some surgeries (ICG).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
This study tests a new, less invasive surgery for early stomach cancer. A special dye is used to find the first lymph node where cancer might spread (sentinel node). If that node is cancer-free, the rest of the stomach may be saved.
This trial compares two ways to treat early stomach cancer: removing it through an endoscope versus doing an operation. It’s meant for a specific stomach-cancer type (undifferentiated) that has not spread, to see which approach may be better.
This trial compares two approaches for early-stage esophageal cancer: removing nearby lymph nodes versus not removing them, after a standard endoscopic removal of the tumor. The goal is to see if removing lymph nodes improves outcomes for patients with T1a stage cancer.
This trial studies a combined surgical approach using a camera through small incisions (laparoscopy) and a flexible tube through the mouth (endoscopy) to treat early-stage stomach cancer. It aims to see if this approach can safely remove the cancer while sparing nearby lymph nodes.
This trial tests a technique called full-time RDI during ESD (a minimally invasive procedure to remove early stomach cancer). The goal is to see if it can lower the chance of serious side effects and shorten the procedure time. If you are scheduled for this surgery and meet the health requirements, you may be able to join.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.